User:Mr. Ibrahem/Sarilumab

Sarilumab, sold under the brand name Kevzara, is a medication used to treat rheumatoid arthritis (RA). It is used for moderate to severe disease when other treatments have not worked. It may also may be used for severe COVID-19 when tocilizumab is not available. It is used by injection under the skin.

The most common side effect is infection. Other side effects may include low neutrophils, low platelets, abnormal lipids, liver problems, allergic reactions, and cancer. Pain may occur at the site of injection. It is a monoclonal antibody which attaches to and blocks the interleukin-6 receptor.

Sarilumab was approved for medical use in the United States and Europe in 2017. In the United States it costs about 7,700 USD per month as of 2021. In the United Kingdom this amount costs the NHS about £1800. In Canada the monthly cost is about 1,500 CAD as of 2017.